Eyal Lifschitz

Mr. Lifschitz is a Co-Founder & General Managing Partner at Peregrine Ventures, an Israeli life sciences venture capital fund that focuses on pharmaceuticals, therapeutic devices and medical software. On behalf of Peregrine, Mr. Lifschitz serves on the boards of Memic Innovative Surgery, Ribon Therapeutics, Nectin Therapeutics, Kahr, Raziel Therapeutics, CardioValve, Cordio Medical and others. Mr. Lifschitz serves as the Chairman of the Israeli Early-Stage Investors association (IEI) & Technology Incubator Forum (ITIF).